Auteur: Thozhukat Sathyapalan

Amirhossein Sahebkar, Pharm D., Ph D.,  is Associate Professor of Pharmaceutical Biotechnology in the School of Pharmacy at the Mashhad University of Medical Sciences in Iran, and Honorary Research Fellow in the School of Health and Medical Sciences at the University of Western Australia. He has published more than 1100 articles on areas including blood lipids, neurovascular diseases, modern medical treatments in cellular, molecular, and animal tissues, and atherosclerosis. He is a highly cited researcher in the field of Pharmacology and Toxicology and has an h-index of 85. Thozhukat Sathyapalan, MD., FRCP., FACP., is the Chair in Academic Diabetes, Endocrinology and Metabolism in Hull York Medical School, University of Hull and Honorary Consultant Endocrinologist at Hull and East Yorkshire Hospitals NHS Trust, United Kingdom. His main area of interest is on modulation of cardiometabolic risk through pharmacological and nutritional interventions. He hasconducted several clinical trials in this area. He has also published and presented extensively in this field.